- Home
- CAMT vs KYMR Comparison
CAMT vs KYMR Comparison
Compare CAMT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAMT
- KYMR
- Stock Information
- Founded
- CAMT 1987
- KYMR 2015
- Country
- CAMT Israel
- KYMR United States
- Employees
- CAMT N/A
- KYMR N/A
- Industry
- CAMT Electronic Components
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- CAMT Technology
- KYMR Health Care
- Exchange
- CAMT Nasdaq
- KYMR Nasdaq
- Market Cap
- CAMT 3.7B
- KYMR 3.0B
- IPO Year
- CAMT 2000
- KYMR 2020
- Fundamental
- Price
- CAMT $74.07
- KYMR $41.96
- Analyst Decision
- CAMT Strong Buy
- KYMR Buy
- Analyst Count
- CAMT 6
- KYMR 13
- Target Price
- CAMT $111.50
- KYMR $51.15
- AVG Volume (30 Days)
- CAMT 539.9K
- KYMR 415.6K
- Earning Date
- CAMT 11-12-2024
- KYMR 10-31-2024
- Dividend Yield
- CAMT 1.80%
- KYMR N/A
- EPS Growth
- CAMT 30.62
- KYMR N/A
- EPS
- CAMT 2.18
- KYMR N/A
- Revenue
- CAMT $400,631,000.00
- KYMR $87,563,000.00
- Revenue This Year
- CAMT $36.26
- KYMR N/A
- Revenue Next Year
- CAMT $16.18
- KYMR $21.47
- P/E Ratio
- CAMT $33.96
- KYMR N/A
- Revenue Growth
- CAMT 29.71
- KYMR 86.92
- 52 Week Low
- CAMT $59.33
- KYMR $17.89
- 52 Week High
- CAMT $140.50
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- CAMT 41.99
- KYMR 34.56
- Support Level
- CAMT $78.58
- KYMR $45.16
- Resistance Level
- CAMT $89.94
- KYMR $53.23
- Average True Range (ATR)
- CAMT 4.43
- KYMR 2.58
- MACD
- CAMT -0.12
- KYMR -0.54
- Stochastic Oscillator
- CAMT 10.49
- KYMR 1.66
About CAMT Camtek Ltd.
Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.